Shanghai Simpletouch Robot Co., Ltd. Files for Hong Kong IPO, Ranked Second in China's Percutaneous Puncture Surgical Robot Market

Newtimespace News: According to the HKEX disclosure, Shanghai Simpletouch Robot Co., Ltd. submitted its main board listing application to the Hong Kong Stock Exchange on May 27, 2026, with Everbright Securities International acting as the sole sponsor.

Founded in 2019, Simpletouch Robot is primarily engaged in the R&D, production and commercialization of percutaneous puncture surgical robots. The company's core product, the RC120 Puncture Surgery Navigation and Positioning System, obtained a Class III medical device registration certificate in 2024 and is used for navigation and positioning in adult lung percutaneous puncture surgeries. According to CIC, by trial installation volume in 2024, the RC120 ranked second in China's percutaneous puncture surgical robot market. The company's product portfolio also includes the RC100, a spinal surgery navigation and positioning system, a neurosurgery navigation and positioning system, a CT-integrated puncture surgery navigation and positioning system, and other candidate products, as well as consumables for puncture surgeries.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.